WATERFOOT MEDICAL PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: P81132 | ROSSENDALE, BB4 7DN
Showing results 51-100 of 525
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Folic acid | 775 | 20.4K | £456 | -40.3% ▼ |
| Latanoprost | 771 | 10.2K | £3.5K | +58.8% ▲ |
| Rivaroxaban | 768 | 24.6K | £16.1K | +25.5% ▲ |
| Candesartan cilexetil | 751 | 26.1K | £1.2K | -36.7% ▼ |
| 737 | 1,477 | £53.7K | +35.2% ▲ | |
| Lamotrigine | 708 | 40.8K | £3.4K | +19.9% ▲ |
| Ferrous sulfate | 704 | 31.9K | £1.2K | +36.9% ▲ |
| Thiamine hydrochloride | 697 | 32.3K | £887 | +32.2% ▲ |
| Lisinopril | 691 | 23.5K | £513 | -36.9% ▼ |
| Duloxetine hydrochloride | 689 | 25.3K | £1.7K | +8.4% ▲ |
| Empagliflozin | 688 | 20.4K | £25.3K | +9.9% ▲ |
| 688 | 9,460 | £6.2K | +3.6% ▲ | |
| Hydroxocobalamin | 674 | 935 | £2.0K | +40.1% ▲ |
| Sildenafil (Erectile Dysfunction) | 670 | 5,760 | £807 | +32.9% ▲ |
| Irbesartan | 645 | 22.9K | £892 | +164.7% ▲ |
| Gliclazide | 642 | 43.8K | £1.1K | -24.5% ▼ |
| 634 | 432.9K | £3.4K | -35.6% ▼ | |
| Indapamide | 604 | 19.5K | £943 | -30.0% ▼ |
| Insulin aspart | 603 | 3,707 | £23.9K | +58.4% ▲ |
| Carbocisteine | 597 | 66.1K | £2.1K | +11.8% ▲ |
| Warfarin sodium | 587 | 23.3K | £802 | +24.5% ▲ |
| Pravastatin sodium | 582 | 18.9K | £908 | +79.2% ▲ |
| Finasteride | 562 | 17.6K | £621 | -14.2% ▼ |
| Solifenacin | 549 | 17.8K | £698 | +15.1% ▲ |
| Glucose blood testing reagents | 520 | 54.1K | £9.1K | -34.1% ▼ |
| Mometasone furoate | 514 | 577 | £4.4K | +28.0% ▲ |
| Lercanidipine hydrochloride | 507 | 16.8K | £1.8K | -17.9% ▼ |
| Estradiol | 507 | 68.4K | £10.1K | -38.2% ▼ |
| Famotidine | 504 | 21.6K | £13.9K | +3.3% ▲ |
| Betamethasone valerate | 503 | 46.1K | £1.8K | +30.6% ▲ |
| Other emollient preparations | 493 | 299.5K | £3.8K | -17.9% ▼ |
| Quetiapine | 479 | 19.7K | £4.4K | -23.1% ▼ |
| 474 | 53.5K | £2.5K | +592.0% ▲ | |
| Fexofenadine hydrochloride | 468 | 20.8K | £988 | -45.0% ▼ |
| Hydrocortisone | 463 | 14.4K | £3.1K | +3.3% ▲ |
| Levetiracetam | 458 | 41.3K | £3.1K | +0.0% vs avg |
| Nitrofurantoin | 455 | 5,062 | £2.7K | -4.6% ▼ |
| Mirabegron | 454 | 14.2K | £13.1K | +13.0% ▲ |
| Esomeprazole | 442 | 19.3K | £1.4K | +9.2% ▲ |
| Diltiazem hydrochloride | 442 | 16.6K | £3.4K | +43.9% ▲ |
| Estradiol with progestogen | 422 | 39.3K | £18.5K | +23.8% ▲ |
| 415 | 419 | £18.5K | +33.6% ▲ | |
| Spironolactone | 388 | 12.6K | £1.0K | -28.0% ▼ |
| Flucloxacillin sodium | 383 | 13.2K | £761 | -14.8% ▼ |
| Insulin glargine | 378 | 2,096 | £21.9K | +33.1% ▲ |
| Hydroxychloroquine sulfate | 378 | 13.3K | £623 | +95.2% ▲ |
| Mebeverine hydrochloride | 372 | 26.2K | £2.1K | +19.8% ▲ |
| Desogestrel | 370 | 62.4K | £1.7K | -6.7% ▼ |
| Sumatriptan succinate | 346 | 3,733 | £5.5K | -2.3% ▼ |
| Letrozole | 345 | 10.5K | £1.8K | +84.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.